You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DS-8201a

Showing 1 - 25 of 7,470
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

Completed
Has Results
  • Adenocarcinoma, Gastric
  • Neoplasm, Breast
  • DS-8201a
  • Taipei, Taiwan
  • +1 more
Nov 2, 2022

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))

Active, not recruiting
Has Results
  • Advanced Solid Tumors
  • DS-8201a (DP1)
  • +2 more
  • San Diego, California
  • +13 more
Oct 4, 2022

Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

Active, not recruiting
  • Breast Cancer Stage IV
  • Trastuzumab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022

Advanced Solid Tumor, Breast Cancer Trial in Atlanta (DS-1103a, T-DXd)

Not yet recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Atlanta, Georgia
    Emory University School of Medicine
Mar 1, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Metastatic Cancer Trial in Spain (Tumor and Blood sample collection)

Recruiting
  • Metastatic Cancer
  • Tumor and Blood sample collection
  • Badalona, Barcelona, Spain
  • +14 more
Jan 23, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Tumor Metastasis Trial in Japan, Korea, Republic of, Taiwan (DS-8201a, Ritonavir, Itraconazole)

Active, not recruiting
Has Results
  • Neoplasm Metastasis
  • DS-8201a
  • +2 more
  • Sapporo, Hokkaido, Japan
  • +9 more
Mar 3, 2022

Malignant Tumor of Breast Trial in Japan (DS-8201a)

Completed
Has Results
  • Malignant Neoplasm of Breast
  • DS-8201a
  • Yokohama, Kanagawa, Japan
  • +6 more
Mar 17, 2022

Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

Recruiting
  • Breast Cancer
  • Non-small Cell Lung Carcinoma
  • San Francisco, California
  • +24 more
Nov 30, 2022

Breast Tumors Trial in France (DS-8201a)

Active, not recruiting
  • Breast Tumors
  • DS-8201a
  • Angers, France
  • +20 more
Feb 1, 2022

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

Recruiting
  • Early-stage Breast Cancer
  • +6 more
  • Fullerton, California
  • +8 more
Sep 19, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Kashiwa (Trastuzumab Deruxtecan (T-DXd))

Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab Deruxtecan (T-DXd)
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
Apr 5, 2022

Colorectal Tumor Trial in Worldwide (DS-8201a)

Completed
Has Results
  • Colorectal Neoplasm
  • DS-8201a
  • Duarte, California
  • +24 more
Sep 21, 2021

Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)

Suspended
  • Osteosarcoma
  • Recurrent Osteosarcoma
  • Trastuzumab Deruxtecan
  • Birmingham, Alabama
  • +27 more
Oct 21, 2022

Metastatic Breast Cancer, Chemo-induced Alopecia Trial in Boston (Paxman Scalp Cooling System, Eribulin, Sacituzumab govitecan)

Recruiting
  • Metastatic Breast Cancer
  • Chemotherapy-induced Alopecia
  • Paxman Scalp Cooling System
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Adenocarcinoma Gastric Stage IV With Metastases, Adenocarcinoma - GEJ Trial in Worldwide (Trastuzumab deruxtecan)

Active, not recruiting
Has Results
  • Adenocarcinoma Gastric Stage IV With Metastases
  • Adenocarcinoma - GEJ
  • Trastuzumab deruxtecan
  • Duarte, California
  • +36 more
Jan 24, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Breast Cancer Trial in Worldwide (DS-8201a)

Active, not recruiting
Has Results
  • Breast Cancer
  • DS-8201a
  • Anchorage, Alaska
  • +98 more
Oct 17, 2022

Tumor, Gastrointestinal Trial in Japan, Korea, Republic of (DS-8201a, Physician's Choice)

Completed
Has Results
  • Neoplasm, Gastrointestinal
  • DS-8201a
  • Physician's Choice
  • Nagoya, Aichi, Japan
  • +65 more
Mar 17, 2022

Advanced Colorectal Cancer Trial in Worldwide (DS-8201a 5.4 mg/kg Q3W, DS-8201a 6.4 mg/kg Q3W)

Active, not recruiting
  • Advanced Colorectal Cancer
  • DS-8201a 5.4 mg/kg Q3W
  • DS-8201a 6.4 mg/kg Q3W
  • Louisville, Kentucky
  • +44 more
Jun 10, 2022

Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in China (Trastuzumab Deruxtecan)

Recruiting
  • Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Trastuzumab Deruxtecan
  • Beijing, China
  • +25 more
Jul 27, 2022